Home
Optimer Pharmaceuticals

Optimer Pharmaceuticals Market Share Analysis for May 2026

Cubist is a bio-pharmaceutical company leading the battle against superbugs and developing new therapies to treat infections in the US and globally.

Health > Biotechnology and Pharmaceuticals

Domainoptimerpharma.com

Year Founded1998

Employees201 - 500

Annual Revenue$75M - $100M

Optimer Pharmaceuticals

Optimer Pharmaceuticals (including company regionals)

optimerpharma.com

See more website traffic and engagement information

Optimer Pharmaceuticals Revenue up to May 2026 is 75M - 100M

revenue generated by Optimer Pharmaceuticals top domains

Optimer Pharmaceuticals top domains revenue over 3 years

Revenue for Optimer Pharmaceuticals top domains

optimerpharma.com75M - 100M

See more with Sales Intelligence

Total visits to Optimer Pharmaceuticals's top domains

Understand Optimer Pharmaceuticals market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Optimer Pharmaceuticals's top domains

Analyze Optimer Pharmaceuticals engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Optimer Pharmaceuticals's top domains

See how Optimer Pharmaceuticals keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Optimer Pharmaceuticals top competitors by domain

Top similar sites in May 2026, ranked by their affinity

cepheid.comCompany NameCepheidEmployees5001 - 10000HQUnited States, California, SunnyvaleAnnual revenue> $1BTotal visits138KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Optimer Pharmaceuticals

These are the website technologies, by industry, used by Optimer Pharmaceuticals top domains

Email Services (1)

Microsoft Exchange Online

News & Signals from Optimer Pharmaceuticals

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsOptimerpharma is developing drug for the treatment of Clostridium difficile infections.Optimer Pharmaceuticals was developing a new drug for the treatment of Clostridium difficile infections (CDI).